Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | HTR1D | P28221 | 10/20 | 0.47 |
| ▸ | HTR1B | P28222 | 7/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | HTR1F | P30939 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7504079 | 0.92 | HSD11B1 (0.52) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4676377 | 0.90 | CYP1A2 (0.52) | HSD11B1HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL4674185 | 0.90 | HSD11B1 (0.55) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4674188 | 0.90 | HSD11B1 (0.55) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4673400 | 0.89 | OPRM1 (0.46) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4673109 | 0.88 | HSD11B1 (0.52) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 | |
| SCHEMBL4670906 | 0.87 | HSD11B1 (0.49) | HSD11B1OPRM1OPRK1OPRL1HTR1D | |
| SCHEMBL4676985 | 0.86 | SLC6A4 (0.50) | SLC6A4HTR1BHTR1AMMP1 | |
| SCHEMBL4671507 | 0.86 | HSD11B1 (0.46) | HSD11B1OPRM1OPRK1OPRL1HTR1D | |
| SCHEMBL4670785 | 0.85 | HSD11B1 (0.51) | HSD11B1OPRM1OPRK1OPRL1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0958287-B2 | SULFAMIDE-METALLOPROTEASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-04-09 | — | — | EP | disclosed |
| EP-0958287-B1 | SULFAMIDE-METALLOPROTEASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2002-09-11 | — | — | EP | disclosed |
| US-6376506-B1 | REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS | SYNTEX (U.S.A.) LLC | 2002-04-23 | — | — | US | disclosed |
| US-6143744-A | Sulfamide-metalloprotease inhibitors | SYNTEX (U.S.A.) INC. (US) | 2000-11-07 | — | — | US | disclosed |
| US-6130220-A | ENZYME INHIBITORS | SYNTEX (USA) INC. (US) | 2000-10-10 | — | — | US | disclosed |
| US-5998412-A | ANTIARTHRITIC AGENTS; OSTEOPOROSIS | SYNTEX (U.S.A.) INC. (US) | 1999-12-07 | — | — | US | disclosed |